LGHT vs. HELX ETF Comparison
Comparison of Langar Global HealthTech ETF (LGHT) to Franklin Genomic Advancements ETF (HELX)
LGHT
Langar Global HealthTech ETF
LGHT Description
LGHT targets the global healthcare technology industry. The fund actively invests in HealthTech companies, which the adviser defines as firms that develop technology designed to create healthcare efficiency by addressing key pain points for patients, providers, payors, and hospitals, including those companies that derive a majority of their revenue from HealthTech products and services. The portfolio construction starts by identifying companies that fit into the advisers HealthTech definition. The remaining companies are screened using a proprietary metric that assesses each firms financial health, involvement in relevant controversies, as well as the strength of its team and culture. Each company is then assigned an industry risk score through an algorithm that defines quantitative and qualitative risk categories and weights them accordingly. Finally, each company is reviewed by an investment committee. However, the portfolio manager still has full discretion over the final selection.
Grade (RS Rating)
Last Trade
$10.35
Average Daily Volume
915
31
HELX
Franklin Genomic Advancements ETF
HELX Description
Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life. Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovationGrade (RS Rating)
Last Trade
$29.53
Average Daily Volume
2,580
53
Performance
Period | LGHT | HELX |
---|---|---|
30 Days | -1.96% | -5.99% |
60 Days | -2.17% | -10.44% |
90 Days | -1.81% | -11.92% |
12 Months | 6.42% |
LGHT Overweight 27 Positions Relative to HELX
Symbol | Grade | Weight | |
---|---|---|---|
ISRG | A | 15.39% | |
GEHC | D | 8.56% | |
RMD | C | 6.71% | |
DXCM | C | 5.51% | |
PODD | C | 5.26% | |
VEEV | C | 5.15% | |
PHG | C | 4.87% | |
ZBH | C | 3.57% | |
ALGN | D | 2.85% | |
MASI | B | 2.46% | |
PRCT | B | 1.27% | |
ALKS | C | 0.66% | |
TNDM | D | 0.54% | |
IRTC | C | 0.44% | |
PRVA | C | 0.44% | |
OMCL | C | 0.42% | |
LFST | B | 0.31% | |
TDOC | C | 0.28% | |
PGNY | F | 0.25% | |
EVH | F | 0.22% | |
SDGR | C | 0.21% | |
GDRX | F | 0.2% | |
ALHC | C | 0.2% | |
PHR | F | 0.17% | |
ACCD | D | 0.07% | |
MODV | C | 0.03% | |
TBRG | B | 0.03% |
LGHT Underweight 49 Positions Relative to HELX
Symbol | Grade | Weight | |
---|---|---|---|
VRTX | D | -5.94% | |
KRYS | C | -4.7% | |
NTRA | A | -4.64% | |
LLY | F | -4.63% | |
REGN | F | -4.3% | |
MEDP | D | -4.07% | |
TMO | F | -4.01% | |
DHR | F | -3.99% | |
UTHR | C | -2.75% | |
AZN | F | -2.34% | |
CDNS | B | -2.34% | |
CTVA | C | -2.29% | |
CRL | D | -2.23% | |
A | D | -2.11% | |
IONS | F | -2.1% | |
INSM | C | -2.08% | |
RVTY | F | -2.01% | |
ALNY | D | -1.98% | |
QGEN | D | -1.96% | |
BRKR | D | -1.94% | |
SRPT | F | -1.5% | |
RARE | F | -1.46% | |
RCKT | F | -1.42% | |
TWST | F | -1.27% | |
LGND | C | -1.27% | |
ICLR | D | -1.25% | |
EXAS | D | -1.2% | |
LH | B | -1.15% | |
RGEN | D | -1.08% | |
BEAM | D | -1.03% | |
TECH | F | -1.01% | |
VYGR | F | -0.99% | |
AZTA | D | -0.95% | |
NBIX | C | -0.94% | |
BBIO | F | -0.91% | |
RXRX | F | -0.69% | |
BIO | C | -0.59% | |
VCYT | B | -0.56% | |
DVAX | C | -0.53% | |
NTLA | F | -0.51% | |
CDMO | A | -0.51% | |
CRSP | D | -0.5% | |
AVTR | F | -0.46% | |
BMY | B | -0.36% | |
CRNX | C | -0.25% | |
BMRN | F | -0.2% | |
ARE | F | -0.15% | |
SLP | D | -0.11% | |
FDMT | F | -0.1% |
LGHT: Top Represented Industries & Keywords
HELX: Top Represented Industries & Keywords